A Multi-Site Investigation into the Effect of HIV Clade on Neurocognition View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2008-2014

FUNDING AMOUNT

3335418 USD

ABSTRACT

DESCRIPTION (provided by applicant): HIV-1 is one of the most genetically diverse pathogens on earth. In fact, some coding regions, such as envelope, can have more than 30% genetic difference between clades. The neurocognitive effects of clade B HIV-1 infection have been well characterized in the developed world; however, there continues to be controversy surronding the effect of non-clade B infection on the neurocognitive functioning. The overarching aims of the proposed study is to 1) characterize and compare the burden of HIV associated neurocognitive disorders (HAND) occurring among individuals living in Brazil, China, India, Romania and the United States and infected with CRF01_AE and clades B, C and F, and 2) evaluate the neurovirulent and neurotropic genotypic determinants between subtypes. Important research questions that remain unanswered include: How do the prevalence, nature and course of HAND in various parts of the world compare when analyzed by population and subtype? What specific viral genetic characteristics are associated with neurovirulence and seeding of the central nervous system (CNS)? The current proposal is designed to systematically address these issues by: 1) determining the differential effect of HIV subtype on neurocognitive performance by measuring HAND using standardized measures in previously established cohorts in Brazil (clades B and C), China (CRF01_AE and clades B and C), India (clade C), Romania (clade F) and the United States (clade B), 2) determining viral genetic motifs from HIV RNA that are conserved during HAND by subtype and by study population by performing clade-typing of study participants by generating population based sequences of the env and tat coding regions from HIV RNA and DNA extracted from blood, and 3) determining viral genetic motifs from HIV RNA that are conserved during CNS compartmentalization between clades B and C by performing clonal sequencing of the env and tat coding regions from HIV RNA extracted from paired blood and CSF samples collected from participants with clade B or C infection in Brazil, India and the United States. The comparison of the burden of HAND between groups infected with different HIV clades requires standardized procedures for the measurement of HAND within and across populations. Investigations into clade-specific genotypic determinants of HIV neuropathogenesis and neurotropism requires: 1) well-characterized study populations and biologic samples from study participants, 2) standardization of measurements of neurocognitive functioning, 3) high quality HIV RNA sequencing capability in all research study settings, 4) secure and reliable data management and communication capabilities for sequence and study data between participating sites, and 5) expertise in state-of- the-art genotypic analysis. Our group has demonstrated experience in each of these areas. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8311774

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "3335418"
    }, 
    "description": "DESCRIPTION (provided by applicant): HIV-1 is one of the most genetically diverse pathogens on earth. In fact, some coding regions, such as envelope, can have more than 30% genetic difference between clades. The neurocognitive effects of clade B HIV-1 infection have been well characterized in the developed world; however, there continues to be controversy surronding the effect of non-clade B infection on the neurocognitive functioning. The overarching aims of the proposed study is to 1) characterize and compare the burden of HIV associated neurocognitive disorders (HAND) occurring among individuals living in Brazil, China, India, Romania and the United States and infected with CRF01_AE and clades B, C and F, and 2) evaluate the neurovirulent and neurotropic genotypic determinants between subtypes. Important research questions that remain unanswered include: How do the prevalence, nature and course of HAND in various parts of the world compare when analyzed by population and subtype? What specific viral genetic characteristics are associated with neurovirulence and seeding of the central nervous system (CNS)? The current proposal is designed to systematically address these issues by: 1) determining the differential effect of HIV subtype on neurocognitive performance by measuring HAND using standardized measures in previously established cohorts in Brazil (clades B and C), China (CRF01_AE and clades B and C), India (clade C), Romania (clade F) and the United States (clade B), 2) determining viral genetic motifs from HIV RNA that are conserved during HAND by subtype and by study population by performing clade-typing of study participants by generating population based sequences of the env and tat coding regions from HIV RNA and DNA extracted from blood, and 3) determining viral genetic motifs from HIV RNA that are conserved during CNS compartmentalization between clades B and C by performing clonal sequencing of the env and tat coding regions from HIV RNA extracted from paired blood and CSF samples collected from participants with clade B or C infection in Brazil, India and the United States. The comparison of the burden of HAND between groups infected with different HIV clades requires standardized procedures for the measurement of HAND within and across populations. Investigations into clade-specific genotypic determinants of HIV neuropathogenesis and neurotropism requires: 1) well-characterized study populations and biologic samples from study participants, 2) standardization of measurements of neurocognitive functioning, 3) high quality HIV RNA sequencing capability in all research study settings, 4) secure and reliable data management and communication capabilities for sequence and study data between participating sites, and 5) expertise in state-of- the-art genotypic analysis. Our group has demonstrated experience in each of these areas.", 
    "endDate": "2014-08-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.416868.5", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2551724", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2551724"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01MH083552"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "CRF01_AE", 
      "Env", 
      "Earth", 
      "participants", 
      "standardized measures", 
      "current proposals", 
      "CNS compartmentalization", 
      "study population", 
      "clade B HIV-1 infection", 
      "genotypic determinants", 
      "blood", 
      "comparison", 
      "groups", 
      "Romania", 
      "CSF samples", 
      "clade B", 
      "measurements", 
      "differential effects", 
      "sequence", 
      "experience", 
      "central nervous system", 
      "neurovirulence", 
      "fact", 
      "reliable data management", 
      "China", 
      "biologic samples", 
      "multi-site investigation", 
      "subtypes", 
      "clade-typing", 
      "data", 
      "neurocognitive disorders", 
      "viral genetic motifs", 
      "burden", 
      "India", 
      "genetic differences", 
      "art genotypic analysis", 
      "investigation", 
      "area", 
      "standardization", 
      "controversy", 
      "clonal sequencing", 
      "clade F", 
      "nature", 
      "clade", 
      "envelope", 
      "tat coding regions", 
      "diverse pathogens", 
      "neurotropism", 
      "study participants", 
      "HIV", 
      "cohort", 
      "study", 
      "clade-specific genotypic determinants", 
      "state", 
      "specific viral genetic characteristics", 
      "neurotropic", 
      "HIV subtypes", 
      "HIV neuropathogenesis", 
      "seeding", 
      "course", 
      "expertise", 
      "Brazil", 
      "communication capabilities", 
      "neurocognition", 
      "important research questions", 
      "neurocognitive functioning", 
      "HIV RNA", 
      "HIV clades", 
      "standardized procedure", 
      "infection", 
      "world", 
      "hand", 
      "neurocognitive performance", 
      "high quality HIV RNA sequencing capability", 
      "sites", 
      "neurovirulent", 
      "HIV-1", 
      "different HIV clades", 
      "clade C", 
      "overarching aim", 
      "issues", 
      "various parts", 
      "effect", 
      "research study settings", 
      "United States", 
      "applicants", 
      "DNA", 
      "description", 
      "prevalence", 
      "population", 
      "neurocognitive effects", 
      "individuals", 
      "coding region"
    ], 
    "name": "A Multi-Site Investigation into the Effect of HIV Clade on Neurocognition", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.266100.3", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.266100.3", 
          "name": "UNIVERSITY OF CALIFORNIA SAN DIEGO", 
          "type": "Organization"
        }, 
        "familyName": "SMITH", 
        "givenName": "DAVID MITCHELL", 
        "id": "sg:person.011715773704.36", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.011715773704.36", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2551724"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T11:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_11.xml.gz", 
    "startDate": "2008-09-08T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8311774"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2551724'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2551724'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2551724'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2551724'


 

This table displays all metadata directly associated to this object as RDF triples.

137 TRIPLES      19 PREDICATES      115 URIs      107 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2551724 schema:about anzsrc-for:2211
2 schema:amount N363bd10510af4fb7a6b41a9be096308d
3 schema:description DESCRIPTION (provided by applicant): HIV-1 is one of the most genetically diverse pathogens on earth. In fact, some coding regions, such as envelope, can have more than 30% genetic difference between clades. The neurocognitive effects of clade B HIV-1 infection have been well characterized in the developed world; however, there continues to be controversy surronding the effect of non-clade B infection on the neurocognitive functioning. The overarching aims of the proposed study is to 1) characterize and compare the burden of HIV associated neurocognitive disorders (HAND) occurring among individuals living in Brazil, China, India, Romania and the United States and infected with CRF01_AE and clades B, C and F, and 2) evaluate the neurovirulent and neurotropic genotypic determinants between subtypes. Important research questions that remain unanswered include: How do the prevalence, nature and course of HAND in various parts of the world compare when analyzed by population and subtype? What specific viral genetic characteristics are associated with neurovirulence and seeding of the central nervous system (CNS)? The current proposal is designed to systematically address these issues by: 1) determining the differential effect of HIV subtype on neurocognitive performance by measuring HAND using standardized measures in previously established cohorts in Brazil (clades B and C), China (CRF01_AE and clades B and C), India (clade C), Romania (clade F) and the United States (clade B), 2) determining viral genetic motifs from HIV RNA that are conserved during HAND by subtype and by study population by performing clade-typing of study participants by generating population based sequences of the env and tat coding regions from HIV RNA and DNA extracted from blood, and 3) determining viral genetic motifs from HIV RNA that are conserved during CNS compartmentalization between clades B and C by performing clonal sequencing of the env and tat coding regions from HIV RNA extracted from paired blood and CSF samples collected from participants with clade B or C infection in Brazil, India and the United States. The comparison of the burden of HAND between groups infected with different HIV clades requires standardized procedures for the measurement of HAND within and across populations. Investigations into clade-specific genotypic determinants of HIV neuropathogenesis and neurotropism requires: 1) well-characterized study populations and biologic samples from study participants, 2) standardization of measurements of neurocognitive functioning, 3) high quality HIV RNA sequencing capability in all research study settings, 4) secure and reliable data management and communication capabilities for sequence and study data between participating sites, and 5) expertise in state-of- the-art genotypic analysis. Our group has demonstrated experience in each of these areas.
4 schema:endDate 2014-08-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.416868.5
6 schema:identifier N9b9d1bb310474e67b8627cb96a7ea6e2
7 Nae9df430596e4fe0ac4eb05d2b7685fd
8 schema:inLanguage en
9 schema:keywords Brazil
10 CNS compartmentalization
11 CRF01_AE
12 CSF samples
13 China
14 DNA
15 Earth
16 Env
17 HIV
18 HIV RNA
19 HIV clades
20 HIV neuropathogenesis
21 HIV subtypes
22 HIV-1
23 India
24 Romania
25 United States
26 applicants
27 area
28 art genotypic analysis
29 biologic samples
30 blood
31 burden
32 central nervous system
33 clade
34 clade B
35 clade B HIV-1 infection
36 clade C
37 clade F
38 clade-specific genotypic determinants
39 clade-typing
40 clonal sequencing
41 coding region
42 cohort
43 communication capabilities
44 comparison
45 controversy
46 course
47 current proposals
48 data
49 description
50 different HIV clades
51 differential effects
52 diverse pathogens
53 effect
54 envelope
55 experience
56 expertise
57 fact
58 genetic differences
59 genotypic determinants
60 groups
61 hand
62 high quality HIV RNA sequencing capability
63 important research questions
64 individuals
65 infection
66 investigation
67 issues
68 measurements
69 multi-site investigation
70 nature
71 neurocognition
72 neurocognitive disorders
73 neurocognitive effects
74 neurocognitive functioning
75 neurocognitive performance
76 neurotropic
77 neurotropism
78 neurovirulence
79 neurovirulent
80 overarching aim
81 participants
82 population
83 prevalence
84 reliable data management
85 research study settings
86 seeding
87 sequence
88 sites
89 specific viral genetic characteristics
90 standardization
91 standardized measures
92 standardized procedure
93 state
94 study
95 study participants
96 study population
97 subtypes
98 tat coding regions
99 various parts
100 viral genetic motifs
101 world
102 schema:name A Multi-Site Investigation into the Effect of HIV Clade on Neurocognition
103 schema:recipient Nc2418f87e963461e8471b796df45d8e7
104 sg:person.011715773704.36
105 https://www.grid.ac/institutes/grid.266100.3
106 schema:sameAs https://app.dimensions.ai/details/grant/grant.2551724
107 schema:sdDatePublished 2019-03-07T11:59
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher Nda66d0cb279a4395b10d471d0ed59c41
110 schema:startDate 2008-09-08T00:00:00Z
111 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8311774
112 sgo:license sg:explorer/license/
113 sgo:sdDataset grants
114 rdf:type schema:MonetaryGrant
115 N363bd10510af4fb7a6b41a9be096308d schema:currency USD
116 schema:value 3335418
117 rdf:type schema:MonetaryAmount
118 N9b9d1bb310474e67b8627cb96a7ea6e2 schema:name nih_id
119 schema:value R01MH083552
120 rdf:type schema:PropertyValue
121 Nae9df430596e4fe0ac4eb05d2b7685fd schema:name dimensions_id
122 schema:value 2551724
123 rdf:type schema:PropertyValue
124 Nc2418f87e963461e8471b796df45d8e7 schema:member sg:person.011715773704.36
125 schema:roleName PI
126 rdf:type schema:Role
127 Nda66d0cb279a4395b10d471d0ed59c41 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
130 rdf:type schema:DefinedTerm
131 sg:person.011715773704.36 schema:affiliation https://www.grid.ac/institutes/grid.266100.3
132 schema:familyName SMITH
133 schema:givenName DAVID MITCHELL
134 rdf:type schema:Person
135 https://www.grid.ac/institutes/grid.266100.3 schema:name UNIVERSITY OF CALIFORNIA SAN DIEGO
136 rdf:type schema:Organization
137 https://www.grid.ac/institutes/grid.416868.5 schema:Organization
 




Preview window. Press ESC to close (or click here)


...